Total Assets Summary of Changjiang Pharmaceutical Group Co., Ltd.

Changjiang Pharmaceutical Group Co., Ltd.'s latest annual total assets in 2023 was 3.44 Billion CNY , down -3.71% from previous year.
Changjiang Pharmaceutical Group Co., Ltd.'s latest quarterly total assets in 2024 Q1 was 3.43 Billion CNY , down -0.4% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported annual total assets of 3.57 Billion CNY in 2022, down -15.09% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported annual total assets of 4.21 Billion CNY in 2021, down -10.01% from previous year.
Changjiang Pharmaceutical Group Co., Ltd. reported quarterly total assets of 3.43 Billion CNY for 2024 Q1, down -0.4% from previous quarter.
Changjiang Pharmaceutical Group Co., Ltd. reported quarterly total assets of 3.09 Billion CNY for 2024 Q3, down -0.54% from previous quarter.

Annual Total Assets Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Total Assets of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Year	Total Assets	Total Assets Growth
2023	3.44 Billion CNY	-3.71%
2022	3.57 Billion CNY	-15.09%
2021	4.21 Billion CNY	-10.01%
2020	4.68 Billion CNY	207.46%
2019	1.52 Billion CNY	-26.92%
2018	2.08 Billion CNY	5.85%
2017	1.96 Billion CNY	163.19%
2016	748.1 Million CNY	7.7%
2015	694.64 Million CNY	1.88%
2014	681.84 Million CNY	21.13%
2013	562.91 Million CNY	38.22%
2012	407.27 Million CNY	23.52%
2011	329.72 Million CNY	18.59%
2010	278.03 Million CNY	21.86%
2009	228.16 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	3.1 Billion CNY	-9.45%
2024 Q1	3.43 Billion CNY	-0.4%
2024 Q3	3.09 Billion CNY	-0.54%
2023 Q1	3.66 Billion CNY	2.51%
2023 FY	3.44 Billion CNY	-3.71%
2023 Q4	3.44 Billion CNY	-7.93%
2023 Q3	3.74 Billion CNY	0.27%
2023 Q2	3.73 Billion CNY	1.75%
2022 Q1	4.37 Billion CNY	3.81%
2022 FY	3.57 Billion CNY	-15.09%
2022 Q4	3.57 Billion CNY	-2.54%
2022 Q3	3.67 Billion CNY	-14.19%
2022 Q2	4.27 Billion CNY	-2.2%
2021 Q1	4.76 Billion CNY	1.84%
2021 Q3	4.27 Billion CNY	-0.9%
2021 Q4	4.21 Billion CNY	-1.51%
2021 FY	4.21 Billion CNY	-10.01%
2021 Q2	4.31 Billion CNY	-9.46%
2020 Q3	1.42 Billion CNY	-2.09%
2020 FY	4.68 Billion CNY	207.46%
2020 Q1	1.48 Billion CNY	-2.3%
2020 Q2	1.45 Billion CNY	-2.21%
2020 Q4	4.68 Billion CNY	228.68%
2019 Q1	2.21 Billion CNY	6.25%
2019 Q3	2.12 Billion CNY	-2.89%
2019 Q2	2.19 Billion CNY	-1.08%
2019 FY	1.52 Billion CNY	-26.92%
2019 Q4	1.52 Billion CNY	-28.4%
2018 Q3	2.06 Billion CNY	1.74%
2018 Q2	2.03 Billion CNY	1.27%
2018 Q1	2 Billion CNY	2.02%
2018 Q4	2.08 Billion CNY	0.71%
2018 FY	2.08 Billion CNY	5.85%
2017 Q2	1.8 Billion CNY	137.56%
2017 Q3	1.79 Billion CNY	-0.4%
2017 Q4	1.96 Billion CNY	9.41%
2017 FY	1.96 Billion CNY	163.19%
2017 Q1	760.58 Million CNY	1.67%
2016 Q3	715.15 Million CNY	1.04%
2016 FY	748.1 Million CNY	7.7%
2016 Q4	748.1 Million CNY	4.61%
2016 Q2	707.81 Million CNY	1.42%
2016 Q1	697.88 Million CNY	0.47%
2015 Q2	766.87 Million CNY	4.73%
2015 Q1	732.21 Million CNY	7.39%
2015 FY	694.64 Million CNY	1.88%
2015 Q4	694.64 Million CNY	-7.34%
2015 Q3	749.68 Million CNY	-2.24%
2014 Q4	681.84 Million CNY	-3.77%
2014 Q3	708.56 Million CNY	13.92%
2014 FY	681.84 Million CNY	21.13%
2014 Q2	622 Million CNY	-0.62%
2014 Q1	625.9 Million CNY	11.19%
2013 Q1	- CNY	0.0%
2013 FY	562.91 Million CNY	38.22%
2013 Q4	562.91 Million CNY	0.0%
2012 FY	407.27 Million CNY	23.52%
2011 FY	329.72 Million CNY	18.59%
2010 FY	278.03 Million CNY	21.86%
2009 FY	228.16 Million CNY	0.0%

Peer Total Assets Comparison of Changjiang Pharmaceutical Group Co., Ltd.

Name	Total Assets	Total Assets Difference
Shenzhen Neptunus Bioengineering Co., Ltd.	32.3 Billion CNY	89.334%
Anhui Fengyuan Pharmaceutical Co., Ltd.	4.39 Billion CNY	21.533%
Dong-E-E-Jiao Co.,Ltd.	13.3 Billion CNY	74.104%
Livzon Pharmaceutical Group Inc.	25.04 Billion CNY	86.242%
Hainan Haiyao Co., Ltd.	7.36 Billion CNY	53.224%
Tus-Pharmaceutical Group Co., Ltd.	1.15 Billion CNY	-199.339%
Jilin Aodong Pharmaceutical Group Co., Ltd.	32.26 Billion CNY	89.321%
Changchun High-Tech Industries (Group) Inc.	30.74 Billion CNY	88.792%
Apeloa Pharmaceutical Co.,Ltd	12.76 Billion CNY	73.012%
PKU HealthCare Corp.,Ltd.	2.43 Billion CNY	-41.319%
Chengdu Huasun Technology Group Inc., Ltd.	2.13 Billion CNY	-61.509%
Dezhan Healthcare Company Limited	5.37 Billion CNY	35.936%
Jinling Pharmaceutical Company Limited	4.55 Billion CNY	24.278%
Jiuzhitang Co., Ltd.	5.32 Billion CNY	35.349%
Huapont Life Sciences Co., Ltd.	30.72 Billion CNY	88.786%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	7.98 Billion CNY	56.856%
Shandong Wohua Pharmaceutical Co., Ltd.	1.14 Billion CNY	-201.017%
Hengkang Medical Group Co., Ltd.	6.08 Billion CNY	43.328%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	6.45 Billion CNY	46.648%
Qianjiang Yongan Pharmaceutical Co., Ltd.	2.34 Billion CNY	-46.807%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	19.2 Billion CNY	82.057%
Jinhe Biotechnology CO., LTD.	5.45 Billion CNY	36.819%
Teyi Pharmaceutical Group Co.,Ltd	2.51 Billion CNY	-37.137%
Kunming Longjin Pharmaceutical Co., Ltd.	631.63 Million CNY	-445.53%
Beijing Aosaikang Pharmaceutical Co., Ltd.	3.52 Billion CNY	2.217%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	8.52 Billion CNY	59.603%
Anhui Huangshan Capsule Co., Ltd.	1.1 Billion CNY	-212.375%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	2.12 Billion CNY	-62.152%
Zhuhai Rundu Pharmaceutical Co., Ltd.	2.22 Billion CNY	-54.673%
Huaren Pharmaceutical Co., Ltd.	5.16 Billion CNY	33.295%
Tianjin Ringpu Bio-Technology Co.,Ltd.	6.59 Billion CNY	47.759%
Shanxi Zhendong Pharmaceutical Co.,Ltd	6.18 Billion CNY	44.248%
Fuan Pharmaceutical (Group) Co., Ltd.	5.97 Billion CNY	42.339%
Hybio Pharmaceutical Co., Ltd.	3.27 Billion CNY	-5.144%
Baotou Dongbao Bio-Tech Co.,Ltd	2.74 Billion CNY	-25.665%
Hunan Er-Kang Pharmaceutical Co., Ltd	5.47 Billion CNY	37.111%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	5.26 Billion CNY	34.499%
Fujian Cosunter Pharmaceutical Co., Ltd.	1.61 Billion CNY	-113.428%
Beijing Science Sun Pharmaceutical Co., Ltd.	3.62 Billion CNY	4.871%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	930.4 Million CNY	-270.35%
Hainan Poly Pharm. Co., Ltd	6.28 Billion CNY	45.19%
Jiangxi Synergy Pharmaceutical Co., Ltd.	3.22 Billion CNY	-6.963%
Wuhan Hiteck Biological Pharma Co.,Ltd	2.97 Billion CNY	-15.97%
Shandong Xinhua Pharmaceutical Company Limited	8.35 Billion CNY	58.755%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	6.33 Billion CNY	45.634%
PharmaBlock Sciences (Nanjing), Inc.	5.1 Billion CNY	32.49%
Jinghua Pharmaceutical Group Co., Ltd.	3.18 Billion CNY	-8.187%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	7.52 Billion CNY	54.179%
Betta Pharmaceuticals Co., Ltd.	9.14 Billion CNY	62.329%
Tibet AIM Pharm. Inc.	927.74 Million CNY	-271.413%
Shenzhen Kangtai Biological Products Co., Ltd.	15.08 Billion CNY	77.158%
Shandong Shanda Wit Science and Technology Co., Ltd.	5.19 Billion CNY	33.714%
Pacific Shuanglin Bio-pharmacy Co., LTD	8.63 Billion CNY	60.075%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	3.01 Billion CNY	-14.098%
Xiamen Kingdomway Group Company	5.35 Billion CNY	35.634%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	1.43 Billion CNY	-140.445%
Walvax Biotechnology Co., Ltd.	15.58 Billion CNY	77.896%
Sunflower Pharmaceutical Group Co.,Ltd	6.88 Billion CNY	49.93%
Harbin Gloria Pharmaceuticals Co., Ltd	3.15 Billion CNY	-9.304%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	40.14 Billion CNY	91.417%
Hunan Hansen Pharmaceutical Co., Ltd.	2.33 Billion CNY	-47.476%
Changzhou Qianhong Biopharma CO.,LTD	2.76 Billion CNY	-24.572%
Shenzhen Weiguang Biological Products Co., Ltd.	2.87 Billion CNY	-19.778%
Honz Pharmaceutical Co., Ltd.	2.16 Billion CNY	-59.111%
Northeast Pharmaceutical Group Co., Ltd.	15.27 Billion CNY	77.44%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	4.52 Billion CNY	23.772%
Guizhou Xinbang Pharmaceutical Co., Ltd.	9.24 Billion CNY	62.728%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	5.78 Billion CNY	40.391%
Zhejiang Yatai Pharmaceutical Co., Ltd.	1.42 Billion CNY	-141.068%
Zhejiang NHU Company Ltd.	39.15 Billion CNY	91.2%
ApicHope Pharmaceutical Co., Ltd	4.4 Billion CNY	21.781%
Shanghai Kaibao Pharmaceutical CO.,Ltd	4.57 Billion CNY	24.76%
Beijing SL Pharmaceutical Co., Ltd.	6.27 Billion CNY	45.112%
Yunnan Baiyao Group Co.,Ltd	53.78 Billion CNY	93.593%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	1.33 Billion CNY	-157.79%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	1.54 Billion CNY	-123.357%
Guangdong Lifestrong Pharmacy Co., Ltd.	855.53 Million CNY	-302.76%
Huadong Medicine Co., Ltd	33.5 Billion CNY	89.717%
Jiangsu Nhwa Pharmaceutical Co., LTD	7.32 Billion CNY	52.979%
Harbin Medisan Pharmaceutical Co., Ltd.	3.44 Billion CNY	-0.081%
LanZhou Foci Pharmaceutical Co.,Ltd.	2.52 Billion CNY	-36.298%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	11.83 Billion CNY	70.885%
Beijing Beilu Pharmaceutical Co., Ltd	2.81 Billion CNY	-22.215%
Nanjing Hicin Pharmaceutical Co., Ltd.	1.41 Billion CNY	-142.848%
Renhe Pharmacy Co., Ltd.	7.44 Billion CNY	53.715%
Chongqing Pharscin Pharmaceutical Co., Ltd.	1.85 Billion CNY	-86.111%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	6.99 Billion CNY	50.724%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	5.11 Billion CNY	32.666%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	7.34 Billion CNY	53.113%

Global Stocks Search

Changjiang Pharmaceutical Group Co., Ltd. (300391.SZ)

Total Assets Summary of Changjiang Pharmaceutical Group Co., Ltd.

Annual Total Assets Chart of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Historical Annual Total Assets of Changjiang Pharmaceutical Group Co., Ltd. (2023 - 2009)

Peer Total Assets Comparison of Changjiang Pharmaceutical Group Co., Ltd.